2023 | Buddlejasaponin IV induces apoptotic cell death by activating the mitochondrial‑dependent apoptotic pathway and reducing α2β1 integrin‑mediated adhesion in HT‑29 human colorectal cancer cells | ONCOLOGY REPORTS |
2022 | Platycodin D Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Blocking the Activation of Mitogen-Activated Protein Kinases and the Production of Interleukin-8 | AMERICAN JOURNAL OF CHINESE MEDICINE |
2022 | Direct Contact with Platelets Induces Podoplanin Expression and Invasion in Human Oral Squamous Cell Carcinoma Cells
| BIOMOLECULES & THERAPEUTICS |
2021 | Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment
| FRONTIERS IN IMMUNOLOGY |
2019 | CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion | JOURNAL OF CLINICAL INVESTIGATION |
2018 | Artemisinin-Daumone Hybrid Inhibits Cancer Cell-Mediated Osteolysis by Targeting Cancer Cells and Osteoclasts
| CELLULAR PHYSIOLOGY AND BIOCHEMISTRY |
2018 | Platycarya strobilacea leaf extract inhibits tumor necrosis factor-α production and bone loss induced by Porphyromonas gingivalis-derived lipopolysaccharide | ARCHIVES OF ORAL BIOLOGY |
2017 | Protective Effect of White-fleshed Peach (Prunus persica (L.) Batsch) on Chronic Nicotine-induced Toxicity
| JOURNAL OF CANCER PREVENTION |
2017 | Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts
| SCIENTIFIC REPORTS |
2017 | Liensinine and Nuciferine, Bioactive Components of Nelumbo nucifera, Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss
| EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE |
2017 | Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis
| SCIENTIFIC REPORTS |
2017 | Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma
| ONCOTARGET |
2016 | The Inhibitory Effects of Forsythia Koreana Extracts on the Metastatic Ability of Breast Cancer Cells and Bone Resorption by Osteoclasts
| JOURNAL OF CANCER PREVENTION |
2015 | Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells
| JOURNAL OF CANCER PREVENTION |
2015 | Loss of RUNX3 expression promotes cancer-associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non-small cell lung cancer
| JOURNAL OF PATHOLOGY |
2015 | Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible
| JOURNAL OF APPLIED ORAL SCIENCE |
2015 | Platycodin D Blocks Breast Cancer-Induced Bone Destruction by Inhibiting Osteoclastogenesis and the Growth of Breast Cancer Cells | CELLULAR PHYSIOLOGY AND BIOCHEMISTRY |
2015 | 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss
| PLOS ONE |
2015 | Type I saikosaponins a and d inhibit osteoclastogenesis in bone marrow-derived macrophages and osteolytic activity of metastatic breast cancer cells
| EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE |
2014 | Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment | TOXICOLOGY AND APPLIED PHARMACOLOGY |
2013 | The Inhibitory Effect of Roasted Licorice Extract on Human Metastatic Breast Cancer Cell-Induced Bone Destruction | PHYTOTHERAPY RESEARCH |
2012 | Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption | ORAL ONCOLOGY |